Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Birds at a college changed beak shapes during the pandemic. It might be a case of rapid evolution - 2Clones of Stumpy, Washington D.C.'s beloved cherry blossom tree, have flowered for the first time
- 3Robert Irwin on winning 'Dancing With the Stars' 10 years after sister Bindi: 'This was everything I dreamed it would be and so much more'
- 4Pain at the pump for Hampton Roads residents
- 5IDF: Staying in West Bank refugee camps will quell lone-wolf terror
- Photos: Hundreds Gather at Bondi Beach After Deadly Attack
- The most effective method to Consummate the Specialty of Handshaking in Business and Group environments
- Tech for Wellbeing: Applications and Devices for a Better You
- Grasping the Commencement of Criminal Cases: An Extensive Outline
- 7 Fast Approaches to Let loose Space on Your Telephone in a flash
- Olivia Rodrigo announces 3rd album, 'You Seem Pretty Sad for a Girl So in Love,' set to debut in June
- Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial
- Israeli strikes in Gaza kill 25 people, Hamas health authority says
- UN rights chief: Israel's new Gaza aid agency rules 'outrageous'
